Gabrielle deVeber, MD
The Hospital for Sick Children
Staff Neurologist
Neurology
Research Institute
Senior Scientist
Child Health Evaluative Sciences
University of Toronto
Professor
Department of Paediatrics
Other Positions
Children's Hospital at Hamilton Health Sciences Corporation
Consultant
Phone: 416-813-7721
Fax: 416-813-6334
e-mail: gabrielle.deveber@sickkids.ca
Brief Biography
Dr. deVeber has been a staff neurologist in the Division of Neurology, as part-time consultant since 1995 and joined the full time staff in 1998. She is the Director of the Children’s Stroke Program at HSC. Dr. deVeber holds a Scientist appointment with the Research Institute’s Population Health Sciences Program and is an Associate Professor at the University of Toronto. Dr. deVeber holds several grants from the following agencies: Heart and Stroke Foundation of Canada, the Canadian Institute for Health Research; she also holds several institutional grants and one funded by a private children’s research foundation.
Clinical Care Activities
Children with stroke.
Areas of Specialty
Paediatric Stroke
Academic Background
Research:
Hamilton Civic Hospitals Research Center and McMaster University, Hamilton, 1995-07-01 - 1998-07-01
Clinical: Pediatric Neurorehabilitation
Spaulding Rehabilitation Hospital, Electromyography, Mass. General Hospital, 1990-07-01 - 1991-07-01
Research Interests
The Children’s Stroke Project and Canadian Paediatric Ischemic Stroke Registry:
The Children’s Stroke Project, a number of inter-related studies of childhood stroke caused by blood clots. The Canadian Paediatric Ischemic Stroke Registry has studied stroke in more than 800 infants and children at the 16 children’s hospitals in Canada. At least 3.2 per 100,000 children per year suffer stroke in Canada. Our studies in HSC children are defining important causes for stroke including chicken pox and anticardiolipin antibodies, a clotting problem. We are also studying treatments and outcomes. The HSC Stroke Outcome Study has found disability in over 40%, recurrent events in 20% and seizures and headaches in another 25%. Finally we are developing multinational studies of treatments for childhood stroke with collaborators in the UK and USA.
Research Activities
Safety and feasibility of low molecular weight heparin in neonates; a population based cohort study of incidence, health care utilization and health outcomes in children with stroke.
Further Research Activities
International clinical trials in childhood stroke.
Achievements
July 2001 - July 2006 "Stroke Investigator Award" Research Scholar
July 1998 - July 2001 "Stroke Investigator Award": Phase II, Junior Faculty
July 1995 - 1998 Heart and Stroke Foundation of Ontario "Stroke Investigator Award" - Research Fellow
Publications
Golomb M, MacGregor D, Domi T, Armstrong D, McCrindle B, Mayank S, and deVeber G. Presumed pre-or perinatal arterial ischemic stroke: risk factors and outcomes. Annals of Neurology 2001; 50(2):163 - 168
deVeber G, Andrew M, Adams C et al for The Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in childhood. NEJM 2001: Aug 9; 345:417-423
Askalan R, Laughlin S, Mayank S, Chan A, MacGregor D, Curtis R, Meaney B, deVeber G. Chicken pox and stroke in childhood: A study of frequency and causation. Stroke 2001; 32:1257-1262
Lanthier S, Lortie A, Michaud J, Laxer R, Jay V, deVeber G. Isolated angiitis of the CNS in children. Neurology 2001; 56:837-842
deVeber G, MacGregor D, Curtis R and Mayank S. Neurological outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000;15:316-324
Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54(2):371-8